Vanguard Personalized Indexing Management
EW icon

Vanguard Personalized Indexing Management’s Edwards Lifesciences EW Stock Holding History

Vanguard Personalized Indexing Management’s Portfolio EW Stock Details EW Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$7.98M Buy
88,167
+1,802
+2% +$151K 0.07% 246
2026
Q1 		$6.92M Buy
86,365
+346
+0.4% +$28.5K 0.07% 247
2025
Q4 		$7.33M Buy
86,019
+3,733
+5% +$306K 0.07% 223
2025
Q3 		$6.4M Sell
82,286
-683
-0.8% -$53.4K 0.07% 249
2025
Q2 		$6.49M Buy
82,969
+19,826
+31% +$1.48M 0.07% 229
2025
Q1 		$4.58M Buy
63,143
+2,018
+3% +$144K 0.07% 264
2024
Q4 		$4.53M Buy
61,125
+12,441
+26% +$871K 0.07% 244
2024
Q3 		$3.21M Sell
48,684
-13,306
-21% -$967K 0.05% 323
2024
Q2 		$5.73M Buy
61,990
+4,825
+8% +$427K 0.11% 147
2024
Q1 		$5.46M Buy
57,165
+14,234
+33% +$1.2M 0.12% 158
2023
Q4 		$3.27M Sell
42,931
-4,034
-9% -$281K 0.08% 219
2023
Q3 		$3.25M Sell
46,965
-5,277
-10% -$424K 0.1% 196
2023
Q2 		$4.93M Buy
52,242
+3,320
+7% +$289K 0.15% 113
2023
Q1 		$4.05M Buy
48,922
+12,273
+33% +$965K 0.14% 130
2022
Q4 		$2.73M Sell
36,649
-6,777
-16% -$522K 0.11% 180
2022
Q3 		$3.59M Sell
43,426
-1,424
-3% -$137K 0.16% 116
2022
Q2 		$4.26M Buy
44,850
+17,995
+67% +$1.86M 0.2% 87
2022
Q1 		$3.16M Buy
26,855
+3,791
+16% +$425K 0.15% 111
2021
Q4 		$2.99M Buy
23,064
+6,810
+42% +$794K 0.18% 102
2021
Q3 		$1.84M Buy
16,254
+2,109
+15% +$241K 0.17% 116
2021
Q2 		$1.47M Buy
14,145
+2,876
+26% +$271K 0.15% 134
2021
Q1 		$943K Buy
+11,269
New +$953K 0.14% 160
2020
Q4 		– Sell
-7,321
Closed -$584K – 563
2020
Q3 		$584K Buy
7,321
+3,251
+80% +$254K 0.16% 152
2020
Q2 		$281K Buy
+4,070
New +$289K 0.13% 204

Other funds holding EW

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return
DZ Bank
DZ Bank Frankfurt Am Main, Germany $130B AUM 46.38% 1-Year Est. Return
Ninety One (UK)
Ninety One (UK) London, United Kingdom $44.7B AUM 17.24% 1-Year Est. Return

Vanguard Personalized Indexing Management's EW Position: Q2 2026 in Review

Vanguard Personalized Indexing Management increased its Edwards Lifesciences (EW) stake by 2.1% in Q2 2026, buying an estimated $151K and bringing the position to 88,167 shares worth $7.98M. The position accounts for 0.07% of the portfolio, ranked #246.

Vanguard Personalized Indexing Management first reported a position in EW in Q2 2020 and has held it in 24 quarters since. 1,334 funds tracked by Wall St. Rank hold EW as of Q2 2026.

  • Vanguard Personalized Indexing Management held 88,167 shares of Edwards Lifesciences worth $7.98M as of Q2 2026.
  • Vanguard Personalized Indexing Management bought 1,802 Edwards Lifesciences shares in Q2 2026, an estimated $151K.
  • Edwards Lifesciences made up 0.07% of Vanguard Personalized Indexing Management's portfolio in Q2 2026, its #246 holding.
  • Vanguard Personalized Indexing Management first reported a position in Edwards Lifesciences in Q2 2020 and has held it in 24 quarters since.
  • 1,334 funds tracked by Wall St. Rank held Edwards Lifesciences as of Q2 2026.

Based on Vanguard Personalized Indexing Management's 13F filing for Q2 2026, filed 11 Aug 2026.